Company · CIK 1645569

# DICE Therapeutics, Inc.

| CIK | [1645569](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001645569) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-11-12 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-267702 | Shelf Effective | 2022-10-03 | 2023-08-10 | 5 |
| 333-270581 | Shelf Effective | 2023-03-15 | 2023-03-15 | 1 |
| 333-259061 | IPO Final prospectus | 2021-08-25 | 2021-09-16 | 5 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-08-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1645569/999999999523002334/9999999995-23-002334-index.htm) Declared effective | 333-267702 | 9999999995-23-002334 |
| 2023-03-15 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1645569/000119312523071466/0001193125-23-071466-index.htm) Shelf registered | 333-270581 | 0001193125-23-071466 |
| 2022-10-13 | [424B5](https://www.sec.gov/Archives/edgar/data/1645569/000119312522262154/0001193125-22-262154-index.htm) Shelf takedown | 333-267702 | 0001193125-22-262154 |
| 2022-10-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1645569/000119312522260619/0001193125-22-260619-index.htm) Shelf takedown | 333-267702 | 0001193125-22-260619 |
| 2022-10-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1645569/999999999522002992/9999999995-22-002992-index.htm) Declared effective | 333-267702 | 9999999995-22-002992 |
| 2022-10-03 | [S-3](https://www.sec.gov/Archives/edgar/data/1645569/000119312522256208/0001193125-22-256208-index.htm) Shelf registered | 333-267702 | 0001193125-22-256208 |
| 2021-09-16 | [424B4](https://www.sec.gov/Archives/edgar/data/1645569/000119312521274351/0001193125-21-274351-index.htm) Final prospectus | 333-259061 | 0001193125-21-274351 |
| 2021-09-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1645569/999999999521003516/9999999995-21-003516-index.htm) Declared effective | 333-259061 | 9999999995-21-003516 |
| 2021-09-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1645569/000119312521268271/0001193125-21-268271-index.htm) Amendment | 333-259061 | 0001193125-21-268271 |
| 2021-08-27 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1645569/000119312521259250/0001193125-21-259250-index.htm) Amendment | 333-259061 | 0001193125-21-259250 |
| 2021-08-25 | [S-1](https://www.sec.gov/Archives/edgar/data/1645569/000119312521256368/0001193125-21-256368-index.htm) Registration filed | 333-259061 | 0001193125-21-256368 |
| 2021-07-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1645569/000095012321008434/0000950123-21-008434-index.htm) Draft made public | 377-05139 | 0000950123-21-008434 |

[All filings of this company](https://equitycapital.markets/filings?cik=1645569) · [CSV](https://equitycapital.markets/filings.csv?cik=1645569)

---
Source page: https://equitycapital.markets/company/1645569 · Data: U.S. SEC EDGAR · CC BY 4.0